Aimei Health Technology (NASDAQ:AFJK) Upgraded by Wall Street Zen to Sell Rating

Wall Street Zen upgraded shares of Aimei Health Technology (NASDAQ:AFJK) to a sell rating in a research report sent to investors on Saturday.

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

Aimei Health Technology Stock Up 20.0%

NASDAQ:AFJK opened at $55.23 on Friday. The company has a market cap of $338.01 million, a P/E ratio of 263.01 and a beta of -3.70. The firm’s 50 day moving average is $35.47 and its two-hundred day moving average is $19.82. Aimei Health Technology has a fifty-two week low of $6.75 and a fifty-two week high of $130.37.

Aimei Health Technology (NASDAQ:AFJK) last released its quarterly earnings data on Tuesday, November 18th. The company reported $0.06 EPS for the quarter.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Wellspring Financial Advisors LLC acquired a new stake in shares of Aimei Health Technology in the second quarter valued at about $133,000. Dakota Wealth Management acquired a new position in Aimei Health Technology during the 4th quarter worth approximately $406,000. Clear Street LLC boosted its holdings in Aimei Health Technology by 63.8% in the 2nd quarter. Clear Street LLC now owns 39,525 shares of the company’s stock worth $441,000 after acquiring an additional 15,399 shares during the period. Clear Street Group Inc. acquired a new stake in Aimei Health Technology in the third quarter valued at approximately $691,000. Finally, Quarry LP raised its stake in shares of Aimei Health Technology by 6.4% during the third quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after purchasing an additional 10,000 shares during the period. Institutional investors and hedge funds own 45.58% of the company’s stock.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.